Osteoporosis: New Deliveries in Bone Health

Osteoporosis: New Deliveries in Bone Health

Episodes

  • Treatment Approaches to Osteoporosis and the Problem of Adherence

    Apr 28, 2014 | 15 min
    Hosted by: John J. Russell Guest: Sol Epstein Osteoporotic fractures occur with great frequency and exact a heavy toll on the individual as well as the community. When a woman is diagnosed with osteoporosis, what are the specific management and treatment goals? Host Dr. John Russell welcomes Sol Epstein, MD, FRCP, FACP, professor of medicine and geriatrics at Mt. Sinai School of Medicine in New York, and adjunct professor of medicine at the University of Pennsylvania. Dr. Epstein is currently a paid consultant to Mission Pharmacal Company.
  • Why We Need To Improve Our Diagnosis and Treatment of Osteoporosis

    Mar 31, 2014 | 18 min
    Hosted by: John J. Russell Guest: Sol Epstein Osteoporotic fractures are among the most prevalent postmenopausal health conditions. In the US alone, more than 1.5 million fractures, including 700,000 vertebral and 300,000 hip fractures, occur in men and women every year. Host Dr. John Russell welcomes Dr. Sol Epstein, an osteoporosis expert who will discuss strategies for dealing with this major public health issue. Dr. Epstein is professor of medicine and geriatrics at Mt. Sinai School of Medicine in New York, and adjunct professor of medicine at the University of Pennsylvania. Dr. Epstein is currently a paid consultant to Mission Pharmacal Company. Sponsored by
  • The Role of Bisphosphonates in Osteoporosis Therapy Today

    Mar 24, 2014 | 18 min
    Hosted by: John J. Russell Guest: Sol Epstein Bisphosphonates were the first class of drugs to be approved for the treatment of osteoporosis, and they remain the foundation of treatment to this day. What is it about this class that makes it so efficacious—and what are some of the pitfalls? Host Dr. John Russell welcomes Sol Epstein, MD, FRCP, FACP, professor of medicine and geriatrics at Mt. Sinai School of Medicine in New York, and adjunct professor of medicine at the University of Pennsylvania. Dr. Epstein is currently a paid consultant to Mission Pharmacal Company.

Chat About This Show